Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-20

Clinical Trial Update: Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the effect of a single-dose potassium supplement in patients with ADHD who do not respond to lidocaine anesthesia, per …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium supplement (potassium supplement)

Snippet

Sponsor: AlkaliDx, Inc. | Conditions: ADHD | Phase 1, Phase 2 | Status: UNKNOWN